non-Hodgkin lymphoma | sciencenewsnet.in

Sunday, December 15, 2019

Latest:

Mayo Clinic researchers present findings at the 2019 San Antonio Breast Cancer Symposium
Study on Negative Perception of Support Groups Garners Research Paper Award
Following the lizard lung labyrinth
Tulane University professor William Brumfield receives Russian Order of Friendship Medal
John Vile is Available to Provide a Non-partisan, Clause-By-Clause Explanation of the U.S. Constitution and the Articles that Govern Impeachment

sciencenewsnet.in

news, journals and articles from all over the world.

Research Results

Retrospective Analysis Identifies Need for Better Classification of Rare Lymphoma

December 4, 2019 sarah Jonas 0 Comments Lymphoma, New Jersey, non-Hodgkin lymphoma, Rutgers University

In what is believed to be one of the largest studies of a rare disorder known as primary cutaneous gamma delta T-cell lymphoma, Rutgers Cancer Institute
investigators and other collaborators examined characteristics, treatment patterns and outcomes and determined accurate diagnosis of the disease requires ongoing analysis.

Research Results

Calcium Signaling Identified as Exploitable Target in Addressing Drug Resistance to Non-Hodgkin Lymphoma Treatment

December 2, 2019 sarah Jonas 0 Comments Antibody Therapy, ASH annual meeting, Drug Resistance, New Jersey, non-Hodgkin lymphoma, Rutgers University

Gene expression profiling and other analyses conducted by Rutgers Cancer Institute of New Jersey researchers and colleagues examining drug resistance to a common antibody therapy for non-Hodgkin lymphoma have identified calcium signaling as a novel and exploitable target in overcoming this treatment obstacle. Results are being presented at the American Society of Hematology Annual Meeting.